Neuro42

San Francisco, United States

Neuro42 is developing and commercializing advanced MRI and robotics technology for diagnosis and image-guided interventions.

$15.6M raised

Aug 2024

Venture - Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Neuro42 raised?

Neuro42 has raised $15.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2024.

Who are Neuro42's investors?

Neuro42's investors include Shangbay Capital, Zepp, Zynext Ventures, National Institute of Neurological Disorders and Stroke, Fred Moll, M.D.

Where is Neuro42 headquartered?

Neuro42 is headquartered in San Francisco, United States.

What does Neuro42 do?

Neuro42 is developing and commercializing advanced MRI and robotics technology for diagnosis and image-guided interventions.

What stage is Neuro42 at?

Neuro42 is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 15, 2024.

MLA

"Neuro42 — Funding & Investors." VCBacked, August 15, 2024, https://www.vcbacked.co/company/neuro42. Accessed July 4, 2026.

APA

VCBacked. (2024). Neuro42 — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/neuro42

Wikipedia (cite web)

{{cite web |title=Neuro42 — Funding & Investors |url=https://www.vcbacked.co/company/neuro42 |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 15, 2024.